Pharmaceutical industry news

UFRJ fortalece cooperação com centro educacional da China

We are EMBL: Pierre Chazelas on connecting people to support science

GSK touts lung cancer data from two drugs

Bringing a High-Potential Bispecific Back from the Brink

Biotech Growth Trust Extends Strong Performance In 2026

SAHPRA and Lesotho strengthen regional collaboration for regulatory excellence

CU Anschutz Scientists Discover Why Shingles Pain Can Last After Virus is Gone

West Pharmaceutical Services at Morgan Stanley conference: growth broadens

Edoardo Porro: il pioniere dell’ostetricia che ha rivoluzionato il parto e ispirato la Clinica Mangiagalli del Policlinico di Milano

The Great Repricing: Seven Assumptions That No Longer Hold

Exclusive—Dr. Michael C. Burgess: We Need a New Playbook to Guard Against Counterfeit Drug Ingredients from China

Sex ratios at birth in the UK: 2019 to 2023

Analysis of male to female birth ratios in the UK for the period 1 January 2019 to 31 December 2023.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Appoints BMS R&D Chief Robert Plenge to Board

Skontaktuj się z nami

The cells that help the tumor: the “family history” of Tregs reconstructed

Wysokiej jakości sterylne ampułki dla przemysłu farmaceutycznego

Rabies post exposure risk assessment

Information for clinicians who require a rabies risk assessment.

KRTL Biotech Appoints Federal Controlled-Substance Compliance Specialist Justin Abril as President-Designate

Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

Electra aims for $342M IPO to power inflammatory drug’s push through phase 3

Scientists discover strange link between low vitamin D and pain

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

Contattaci

Ampolle sterili di alta qualità per l'industria farmaceutica

J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg

GATC Health Joins Critical Path Institute’s New Approach Methodologies Developer Coalition to Advance AI-Enabled Regulatory Science

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 August 2026

ETRA IPO News - Antibody biotech Electra Therapeutics sets terms for $325 million IPO

GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial

Global cancer drug rights dispute settled by Cardiff and Nerviano

ACTO Named Among Everest Group's Top 50™ Pharmaceutical Technology Providers for 2026

BioNTech (NASDAQ: BNTX) lung cancer drug extends survival vs chemo in Phase 3

Major Shift in Biotech Manufacturing Canva

Biographie Jérémie Calais

Leios Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for 10XB-101 for Moderate-to-Severe Submental Fat Fullness

Pulsed Field Ablation for Perimitral Atrial Flutter With Involvement of the Vein of Marshall: A Case Report

Cancer and autoimmune trials define Legend Biotech (LEGN) cell therapy pipeline

BriaCell (BCTX) Phase 3 Trial Safety Endorsement Highlights Market's Cautious Outlook

Effect of Ethanol Infusion via the Vein of Marshall on Atrial Tachyarrhythmia With Mitral Valve Surgical History

Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study

Correcting False Health Claims and Navigating AI-Generated Information — The Monitor

TZIELD (teplizumab) and the Risk of Viral Reactivation

Serious and life-threatening cases of viral reactivation, including Epstein–Barr virus (EBV) and cyt...

A 48-hour home treatment for postpartum depression enters a new study. About 120 participants are planned.

SLS Stock Slumps As Legal Scrutiny Hits Phase 3 Trial

Maharashtra Food and Drug Administration seizes unsafe dairy products

ETF Movement | China Asset Management Hang Seng Biotech ETF (03069) Surges Over 4% Amid Frequent WCLC Clinical Data Releases; Institutions Bullish on Innovative Drug Investment Opportunities

An anxiety treatment met every key goal in a late-stage trial. An FDA meeting is planned for late 2026.

Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.

A breast cancer trial gets a seventh recommendation to continue

Field Safety Notices: 7 September to 11 September 2026

BioMarin Pharmaceutical (NASDAQ:BMRN) Forms Tight Breakout Setup With Strong Technicals

Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)

Immunocore Announces Target Enrollment Achieved in Phase 3 TEBE-AM Trial of KIMMTRAK in Previously Treated Advanced Melanoma

未来の自分を支える健康習慣へ ニコチンアミドモノヌクレオチドと長命草を配合したサプリメント「NMN」を 2026年9月14日に新発売

Israeli Ag-Biotech Company Plans North American Headquarters in Indiana

Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder

West Pharmaceutical stock holds near highs after strong quarterly beat and fresh guidance

Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win